Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PKC
    (71)
  • Apoptosis
    (12)
  • Autophagy
    (10)
  • PKA
    (10)
  • Antibacterial
    (5)
  • ROCK
    (5)
  • Akt
    (4)
  • Endogenous Metabolite
    (4)
  • NF-κB
    (4)
  • CDK
    (3)
Filter
Search Result
Results for "

δpkc

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    75
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    17
    TargetMol | Peptide_Products
  • Natural Products
    20
    TargetMol | Natural_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Cell Research
    1
    TargetMol | Inhibitors_Agonists
Delcasertib
KAI-9803, BMS-875944
T11740949100-39-4
Delcasertib (KAI-9803) is a potent and selective inhibitor of δ-protein kinase C (δPKC).
  • Inquiry Price
Size
QTY
PKCβII Peptide Inhibitor I
T80070862502-26-9
PKCβII Peptide Inhibitor I, a specific PKCβII inhibitor, exhibits cardioprotective properties in a rat cardiac ischemia reperfusion injury model and mitigates vascular endothelial dysfunction [1].
  • Inquiry Price
Size
QTY
PKCε (85-92)
T80248207111-98-6
PKCε (85-92) (ψεRACK) is a peptide and selective PKCε activator that does not affect the activity of other PKC isozymes.PKCε (85-92) induces a pro-angiogenic response in endothelial cells, promotes FGF-2 cytosolization, and regulates VEGF activity.
  • Inquiry Price
Size
QTY
Epsilon-V1-2, Cys-conjugated
T80249
Epsilon-V1-2, a Cys-conjugated, is a biologically active peptide known as the εPKC-specific inhibitor. It hampers εPKC functionality by obstructing its translocation and the phosphorylation of MARCKS, additionally perturbing εPKC's interaction with its anchoring protein, εRACK. The peptide includes a cysteine residue at its C-terminus, facilitating the formation of potential disulfide bonds with carrier proteins. Pyroglutamyl formation can occur spontaneously at the N-terminus if glutamine or glutamic acid is present, enhancing peptide stability against gastrointestinal proteases. Pyroglutamyl peptides, a recognized subset, are accounted for in the peptide's purity during HPLC analysis.
  • Inquiry Price
Size
QTY
ɛPKC(85–92),Myristoylated
T805041072301-79-1
PKC(85-92),Myristoylated is a myristic acid-conjugated, cell-permeable peptide activator of PKC that has been shown to increase nitric oxide (NO) release in cultured human umbilical vein endothelial cells (HUVECs) [1].
  • Inquiry Price
Size
QTY
PKCα (C2-4) inhibitor peptide
T80505
PKCα (C2-4) inhibitor peptide is a specific antagonist to PKCα, preventing the α1A-adrenoreceptor agonist A-61603 [1] from inhibiting I_Kr.
  • Inquiry Price
Size
QTY
PKCθ pseudosubstrate peptide inhibitor,myristoylated
T80507
Myristoylated PKCθ pseudosubstrate peptide inhibitor is a synthetic peptide utilized to investigate the mechanism of action of protein kinase C theta (PKCθ) [1].
  • Inquiry Price
Size
QTY
PKCη pseudosubstrate inhibitor,myristoylated
T80508908012-19-1
Myristoylated PKCη pseudosubstrate inhibitor is a cell-permeable compound utilized to investigate the mechanism of action of PKCη [1].
  • Inquiry Price
Size
QTY
PKC 20-28,myristoylated
Myristoylated protein kinase C inhibitor 20-28
T80509
Myristoylated protein kinase C inhibitor 20-28 (PKC 20-28,myristoylated) is a cell-permeable inhibitor of protein kinase C, utilized in cancer research [1].
  • Inquiry Price
Size
QTY
PKCε inhibitor peptide,myristoylated
Myr‐PKCɛ-
T80511
Myristoylated PKCε inhibitor peptide (Myr-PKCε-) is a cell-permeable inhibitor consisting of a peptide linked to myristic acid that specifically inhibits protein kinase C epsilon (PKCε), consequently diminishing nitric oxide (NO) release in cultured human umbilical vein endothelial cells (HUVECs) [1].
  • Inquiry Price
Size
QTY
TAT-SAMβA
T80514
TAT-SAMβA, an RNAENFDRF (SAMβA) peptide conjugated to the TAT 47–57 protein-derived cell-penetrating peptide, acts as a selective antagonist of the Mfn1-βIIPKC association. It has been shown to protect mouse embryonic fibroblast cells (MEFs) from cytotoxicity induced by oxidative stress [1].
  • Inquiry Price
Size
QTY
N-myristoyl-RKRTLRRL
T80550152246-40-7
N-myristoyl-RKRTLRRL is a compound that impedes the binding of protein kinase C (PKC) substrates and inhibits calcium (Ca2+)- and phosphatidylserine (PS)-dependent phosphorylation of histones, exhibiting an IC50 of 5 μM. Additionally, it demonstrates an inhibitory effect on histone phosphorylation with an IC50 of 80 μM [1] [2].
  • Inquiry Price
Size
QTY
PKC-ε translocation inhibitor peptide
T81449
PKC-ε Translocation Inhibitor Peptide is a selective modulator that controls the FcγR-mediated internalization rate of opsonized beads without affecting FcαR trafficking [1].
  • Inquiry Price
Size
QTY
PKC β pseudosubstrate acetate
Protein kinase C beta pseudosubstrate, PKC β pseudosubstrate acetate (172308-76-8 Free base), PKC beta pseudosubstrate
TP1955L
PKC β pseudosubstrate acetate (PKC β pseudosubstrate acetate (172308-76-8 Free base)) is a selective cell-permeable inhibitor of PKC.
  • Inquiry Price
Size
QTY
Delcasertib acetate
KAI-9803, KID1-1, CS-9803, BMS-875944, Delcasertib acetate(949100-39-4 free base)
T11740L
Delcasertib acetate is a selective δ protein kinase C (δPKC) inhibitor for the study of acute myocardial infarction and pain.
  • Inquiry Price
Size
QTY
PKCε Inhibitor Peptide acetate
PKCε Inhibitor Peptide acetate(182683-50-7 Free base)
T35827L
PKCε Inhibitor Peptide acetate is a selective PKCε inhibitor containing the site for its specific receptor for activated C kinase (RACK). PKCε Inhibitor Peptide acetate inhibits the translocation of PKCε, but not α-, β-, and δPKC.
  • Inquiry Price
Size
QTY
Delcasertib hydrochloride
T73661
Delcasertib (KAI-9803) hydrochloride, a potent and selective δ-protein kinase C (δPKC) inhibitor, shows promise in reducing ischemia and reperfusion injury in animal models of acute myocardial infarction (MI) [1] [2].
  • Inquiry Price
Size
QTY